CCL2 and lobular neoplasia: A combination with urinary EGF seems to greatly improve its predictive properties, with EGF being a marker for tubular damage and MCP-1 reflecting ongoing inflammation, which is a key feature of certain CKD etiologies such as LN, where the early detection of ongoing inflammation through regular screening is crucial for preserving kidney function and avoiding ESKD.